| Bioactivity | Zoracopan is a selective complement factor D (CFD) inhibitor. When administered systemically (orally or intravenously), Zoracopan accumulates and is sustained-released in ocular tissues, primarily in the choroid-retinal pigment epithelium (C-RPE) and/or iridociliary body (I-CB)[1]. |
| CAS | 2243483-63-6 |
| Formula | C31H31BrN6O3 |
| Molar Mass | 615.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ocular drug depot for complement-mediated disorders. WO2021183555A1 - Ocular drug depot for complement-mediated disorders - Google Patents. |
Zoracopan
CAS: 2243483-63-6 F: C31H31BrN6O3 W: 615.52
Zoracopan is a selective complement factor D (CFD) inhibitor. When administered systemically (orally or intravenously),
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.